相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?
Anna S. Berghoff et al.
NATURE REVIEWS NEUROLOGY (2019)
The Hippo Signaling Pathway in Development and Disease
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2019)
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors
Ioannis Kaffes et al.
ONCOIMMUNOLOGY (2019)
Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma
Hans-Georg Wirsching et al.
JCI INSIGHT (2019)
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Xin Cui et al.
BIOMATERIALS (2018)
Concepts for Immunotherapies in Gliomas
Michael Platten et al.
SEMINARS IN NEUROLOGY (2018)
Immune Microenvironment in Glioblastoma Subtypes
Zhihong Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
Konrad Gabrusiewicz et al.
ONCOIMMUNOLOGY (2018)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Pakawat Chongsathidkiet et al.
NATURE MEDICINE (2018)
Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1
Zhi-Fa Wen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune Checkpoints and Innovative Therapies in Glioblastoma
Massimo Romani et al.
FRONTIERS IN ONCOLOGY (2018)
Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype
Smitha Sreedharan et al.
CANCER RESEARCH (2017)
Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas
C. J. Herting et al.
GLIA (2017)
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
Anna C. Filley et al.
ONCOTARGET (2017)
Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin
Yiwen Jiang et al.
CELL REPORTS (2017)
Current Advances in Checkpoint inhibitors: Lessons from non-Central nervous System Cancers and Potential for Glioblastoma
Natasha Lakin et al.
FRONTIERS IN ONCOLOGY (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Laurence P. Diggs et al.
BIOMARKER RESEARCH (2017)
PD-L1 expression and prognostic impact in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus
Nicholas H. Varvel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain
Alice M. Coughlan et al.
STEM CELLS AND DEVELOPMENT (2016)
The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway
Rui Yang et al.
ONCOTARGET (2016)
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Konrad Gabrusiewicz et al.
JCI INSIGHT (2016)
Differential roles of resident microglia and infiltrating monocytes in murine CNS autoimmunity
Anat Shemer et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Tatsuya Ozawa et al.
CANCER CELL (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair
Anat London et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Bleach gel: A simple agarose gel for analyzing RNA quality
Patrick S. Aranda et al.
ELECTROPHORESIS (2012)
Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
Jane R. Engler et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
The role of microglia in central nervous system immunity and glioma immunology
Isaac Yang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2010)
Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice
Noah Saederup et al.
PLOS ONE (2010)
Worse Outcome in Primary Glioblastoma Multiforme With Concurrent Epidermal Growth Factor Receptor and p53 Alteration
Yolanda Ruano et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
Haihao Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma
Dan R. Laks et al.
STEM CELLS (2009)
Modeling Adult Gliomas Using RCAS/t-va Technology
Dolores Hambardzumyan et al.
TRANSLATIONAL ONCOLOGY (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz et al.
JOURNAL OF IMMUNOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
C Dai et al.
GENES & DEVELOPMENT (2001)
T cell-specific loss of Pten leads to defects in central and peripheral tolerance
A Suzuki et al.
IMMUNITY (2001)
Generation and analysis of mice lacking the chemokine fractalkine
DN Cook et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
S Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)